{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:43:01Z","timestamp":1782301381764,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The National Nature Science Fund","award":["82170721"],"award-info":[{"award-number":["82170721"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01184-0","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T07:01:46Z","timestamp":1696489306000},"page":"5367-5376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mild mesangial proliferative IgA nephropathy with and without minimal change disease"],"prefix":"10.1007","volume":"23","author":[{"given":"Shulei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9491-7255","authenticated-orcid":false,"given":"Junjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"1184_CR1","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1523-1755.2004.00837.x","volume":"66","author":"LS Li","year":"2004","unstructured":"Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004;66:920\u20133.","journal-title":"Kidney Int"},{"key":"1184_CR2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ki.2015.252","volume":"88","author":"R Magistroni","year":"2015","unstructured":"Magistroni R, D\u2019Agati VD, Appel GB, Kiryluk K. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy. Kidney Int. 2015;88:974\u201389.","journal-title":"Kidney Int"},{"key":"1184_CR3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0272-6386(97)90456-X","volume":"29","author":"M Haas","year":"1997","unstructured":"Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829\u201342.","journal-title":"Am J Kidney Dis"},{"key":"1184_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0272-6386(85)80120-7","volume":"5","author":"P Sinnassamy","year":"1985","unstructured":"Sinnassamy P, O\u2019Regan S. Mesangial IgA deposits with steroid responsive nephrotic syndrome: probable minimal lesion nephrosis. Am J Kidney Dis. 1985;5:267\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1184_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0272-6386(89)80168-4","volume":"14","author":"IK Cheng","year":"1989","unstructured":"Cheng IK, Chan KW, Chan MK. Mesangial IgA nephropathy with steroid-responsive nephrotic syndrome: disappearance of mesangial IgA deposits following steroid-induced remission. Am J Kidney Dis. 1989;14:361\u20134.","journal-title":"Am J Kidney Dis"},{"key":"1184_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000168050","volume":"10","author":"DM Clive","year":"1990","unstructured":"Clive DM, Galvanek EG. Silva FG Mesangial immunoglobulin A deposits in minimal change nephrotic syndrome: a report of an older patient and review of the literature. Am J Nephrol. 1990;10:31\u20136.","journal-title":"Am J Nephrol"},{"key":"1184_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5414\/CN107682","volume":"79","author":"J Qin","year":"2013","unstructured":"Qin J, Yang Q, Tang X, et al. Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease. Clin Nephrol. 2013;79:37\u201344.","journal-title":"Clin Nephrol"},{"key":"1184_CR8","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2215\/CJN.11951113","volume":"9","author":"LC Herlitz","year":"2014","unstructured":"Herlitz LC, Bomback AS, Stokes MB, Radhakrishnan J, D\u2019Agati VD, Markowitz GS. IgA nephropathy with minimal change disease. Clin J Am Soc Nephrol. 2014;9:1033\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1184_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5414\/CN108727","volume":"85","author":"XW Li","year":"2016","unstructured":"Li XW, Cheng SQ, Liang SS, et al. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease. Clin Nephrol. 2016;85:273\u201381.","journal-title":"Clin Nephrol"},{"key":"1184_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40620-015-0242-9","volume":"29","author":"XW Li","year":"2016","unstructured":"Li XW, Liang SS, Le WB, et al. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease. J Nephrol. 2016;29:567\u201373.","journal-title":"J Nephrol"},{"key":"1184_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0272-6386(85)80044-5","volume":"5","author":"Association of IgA nephropathy with steroid-responsive nephrotic syndrome","year":"1985","unstructured":"Association of IgA nephropathy with steroid-responsive nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group. Am J Kidney Dis. 1985;5:157\u201364.","journal-title":"Am J Kidney Dis"},{"key":"1184_CR12","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.3346\/jkms.2009.24.S1.S44","volume":"24","author":"SM Kim","year":"2009","unstructured":"Kim SM, Moon KC. Clinicopathologic characteristics of IgA nephropathy with steroid-responsive nephrotic syndrome. J Korean Med Sci. 2009;24:S44-49.","journal-title":"J Korean Med Sci"},{"key":"1184_CR13","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/ajcp\/86.6.716","volume":"86","author":"KN Lai","year":"1986","unstructured":"Lai KN, Lai FM, Chan KW, Ho CP, Leung AC, Vallance-Owen J. An overlapping syndrome of IgA nephropathy and lipoid nephrosis. Am J Clin Pathol. 1986;86:716\u201323.","journal-title":"Am J Clin Pathol"},{"key":"1184_CR14","first-page":"139","volume":"12","author":"I Global","year":"2012","unstructured":"Global I. Group OKGW KDIGO clinical practice guideline for lomerulonephritis. Kidney inter. 2012;12:139\u2013274.","journal-title":"Kidney inter"},{"key":"1184_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1681\/ASN.V82199","volume":"8","author":"MG Radford Jr","year":"1997","unstructured":"Radford MG Jr, Donadio JV Jr, Bergstralh EJ. Grande JP predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997;8:199\u2013207.","journal-title":"J Am Soc Nephrol"},{"key":"1184_CR16","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1093\/ndt\/gft211","volume":"28","author":"J Wang","year":"2013","unstructured":"Wang J, Juan C, Huang Q, Zeng C. Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study. Nephrol Dial Transplant. 2013;28:2339\u201345.","journal-title":"Nephrol Dial Transplant"},{"key":"1184_CR17","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.kint.2016.06.020","volume":"90","author":"MC Hogan","year":"2016","unstructured":"Hogan MC, Reich HN, Nelson PJ, et al. The relatively poor correlation between random and\u00a024-hour urine protein excretion in patients with\u00a0biopsy-proven glomerular diseases. Kidney Int. 2016;90:1080\u20139.","journal-title":"Kidney Int"},{"key":"1184_CR18","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91:1014\u201321.","journal-title":"Kidney Int"},{"issue":"100","key":"1184_CR19","first-page":"S1","volume":"2021","author":"Group IGOKGDW KDIGO","year":"2021","unstructured":"Group IGOKGDW KDIGO. Clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;2021(100):S1-s276.","journal-title":"Kidney Int"},{"key":"1184_CR20","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","volume":"27","author":"W Le","year":"2012","unstructured":"Le W, Liang S, Hu Y, et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant. 2012;27:1479\u201385.","journal-title":"Nephrol Dial Transplant"},{"key":"1184_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204.","journal-title":"Crit Care"},{"key":"1184_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2215\/CJN.04820511","volume":"7","author":"JK Kim","year":"2012","unstructured":"Kim JK, Kim JH, Lee SC, et al. Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. Clin J Am Soc Nephrol. 2012;7:427\u201336.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1184_CR23","first-page":"174","volume":"26","author":"KN Lai","year":"1986","unstructured":"Lai KN, Lai FM, Ho CP, Chan KW. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Clin Nephrol. 1986;26:174\u201380.","journal-title":"Clin Nephrol"},{"key":"1184_CR24","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.kint.2020.08.006","volume":"98","author":"M Haas","year":"2020","unstructured":"Haas M, Seshan SV, Barisoni L, et al. Consensus definitions for glomerular lesions by light and electron microscopy: recommendations from a working group of the renal pathology society. Kidney Int. 2020;98:1120\u201334.","journal-title":"Kidney Int"},{"key":"1184_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3109\/01913123.2015.1120837","volume":"40","author":"AA Kurien","year":"2016","unstructured":"Kurien AA, Larsen C, Rajapurkar M, Bonsib SM. Walker P Lack of electron microscopy hinders correct renal biopsy diagnosis: a study from India. Ultrastruct Pathol. 2016;40:14\u20137.","journal-title":"Ultrastruct Pathol"},{"key":"1184_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10157-020-01985-7","volume":"25","author":"G Stefan","year":"2021","unstructured":"Stefan G, Busuioc R, Stancu S, et al. Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome. Clin Exp Nephrol. 2021;25:240\u201350.","journal-title":"Clin Exp Nephrol"},{"key":"1184_CR27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2215\/CJN.07420716","volume":"12","author":"JC Rodrigues","year":"2017","unstructured":"Rodrigues JC, Haas M. Reich HN IgA nephropathy. Clin J Am Soc Nephrol. 2017;12:677\u201386.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1184_CR28","doi-asserted-by":"publisher","first-page":"32806730","DOI":"10.3390\/jcm9082619","volume":"9","author":"WH Cho","year":"2020","unstructured":"Cho WH, Park SH, Choi SK, et al. Characterization of IgA deposition in the kidney of patients with IgA nephropathy and minimal change. J Clin Med. 2020;9:32806730.","journal-title":"J Clin Med"},{"key":"1184_CR29","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser J, von Gersdorff G. Loos M et al Induction of B7\u20131 in podocytes is associated with nephrotic syndrome. J Clin Invest. 2004;113:1390\u20137.","journal-title":"J Clin Invest"},{"key":"1184_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1053\/j.ajkd.2011.07.024","volume":"59","author":"SS Chugh","year":"2012","unstructured":"Chugh SS, Clement LC. Mac\u00e9 C New insights into human minimal change disease: lessons from animal models. Am J Kidney Dis. 2012;59:284\u201392.","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01184-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01184-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T16:19:51Z","timestamp":1702743591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01184-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01184-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"assertion":[{"value":"3 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was carried out according to the principles laid out in the World Medical Association\u2019s Declaration of Helsinki and supported by the Ethics Committee of Zhengzhou University (KY-2022\u20130307). All patients provided written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}